2009 St. Jude Children's Research Hospital Acute Lymphoblastic Leukemia Team
Dario Campana, M.D., Ph.D., Cheng Cheng, Ph.D., James R. Downing, M.D., William E. Evans, Pharm.D., Melissa M. Hudson, M.D., Sima Jeha, M.D., Charles Mullighan, MBBS (Hons), MSc, M.D., Ching-Hon Pui, M.D., Susana C. Raimondi, Ph.D., Mary V. Relling, Pharm.D., Raul C. Ribeiro, M.D.
In recognition of their seminal laboratory discoveries that unraveled mechanisms of leukemogenesis and drug resistance; the identification of novel therapeutic targets; and the integration of biologic, genomic, and pharmacologic discoveries into comprehensive clinical protocols all leading to markedly improved cure rates of children with Acute Lymphoblastic Leukemia.
2008 Team Science Award Winners
Donna G. Albertson, Jane Fridyland, Joe W. Gray, Ajay Jain, Anne H. Kallioniemi, Olli-Pekka Kallioniemi, Robert Nordmeyer, Norma J. Nowak, Daniel Pinkel, Antoine Sniders, Damir Sudar, and Frederick M. Waldmann
In recognition of a team of clinicians, physicists, biochemists, statisticians, computer scientists, and engineers at the University of California San Francisco, the Lawrence Berkeley National Laboratory, and Roswell Park Cancer Institute for the conception, technical implementation, dissemination and pioneering applications of comparative genomic hybridization or CGH, and array CGHin.
2007 University of Michigan-Brigham and Women's Hospital Team
Xuhong Cao, M.S., Arul M. Chinnaiyan, M.D., Ph.D., Saravana Dhanasekaran, Ph.D., Rohit Mehra, M.D., James Montie, M.D., Kenneth Pienta, M.D., Robin Rasor, Daniel Rhodes, Ph.D., Rajal Shah, M.D., Scott A. Tomlins, M.D., Ph.D., Sooryanarayana Varambally, Ph.D., and John Wei, M.D. of the University of Michigan, and Francesca Demichelis, Ph.D., Charles Lee, Ph.D., Sven Perner, M.D., and Mark A. Rubin, M.D. of Brigham and Women's Hospital, Harvard Medical School:
In recognition of their landmark discovery of recurrent gene fusions in a majority of prostate cancers, which has profound clinical and biological implications for understanding prostate cancers, and their embodiment of team science through interdisciplinary and inter-institutional collaboration.